Sugi Predict

Sugi Predict / Compounds / SCHEMBL636908

SCHEMBL636908

SCHEMBL636908

C/C(=C\CCCCN)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAOX Q6QHF9 3/20 0.41
▸ EP300 Q09472 1/20 0.41
▸ CYP2D6 P10635 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ BLM P54132 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ THRB P10828 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PLG P00747 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ TBXAS1 P24557 1/20 0.38
▸ CD81 P60033 1/20 0.37
▸ GABRR3 A8MPY1 1/20 0.36
▸ GABRP O00591 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50381 1.00 PAOX (0.41) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL2370856 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
Hydrochloric Acid SCHEMBL28732738 0.98 BLM (0.41) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL4341980 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL50337 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL6665851 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL2370853 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL2965618 0.98 PAOX (0.45) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL50172 0.93 PAOX (0.38) PAOXEP300CYP2D6NFKB1BLM
SCHEMBL637087 0.93 PAOX (0.38) PAOXEP300CYP2D6NFKB1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111391-B9 NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY FABRE PIERRE DERMO COSMETIQUE (FR) 2013-05-29 — — EP claimed
EP-2111391-B1 NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY FABRE PIERRE DERMO COSMETIQUE (FR) 2012-10-31 — — EP claimed
EP-2111391-A1 NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY Pierre Fabre Dermo-Cosmetique (FR) 2009-10-28 — — EP claimed
WO-2008090073-A1 NEW UNSATURATED FATTY AMINO-ACID DERIVATIVES AND USE THEREOF IN DERMAL COSMETOLOGY PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-07-31 — — WO claimed
WO-2004035666-A2 ANTIMICROBIAL ELASTOMERS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2004-04-29 — — WO claimed
EP-1405878-A1 Polycondensation resins containing aminofunctionalized polymers Creavis Gesellschaft für Technologie und Innovation mbH (DE) 2004-04-07 — — EP claimed
EP-1391153-A1 Method for surface immobilisation of antimicrobial polymers by metal deposition Creavis Gesellschaft für Technologie und Innovation mbH (DE) 2004-02-25 — — EP claimed
WO-2003096809-A1 ANTIMICROBIAL ACTIVE CARBON CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2003-11-27 — — WO claimed
WO-2003068316-A1 COSMETIC FORMULATIONS THAT CONTAIN ANTIMICROBIAL POLYMERS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2003-08-21 — — WO claimed
US-20200282075-A1 ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND ABBVIE DEUTSCHLAND (DE) 2020-09-10 — — US disclosed
EP-3678706-A1 ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND Abbvie Deutschland GmbH & Co. KG (DE) 2020-07-15 — — EP disclosed
WO-2019048531-A1 ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND AbbVie Deutschland GmbH & Co. KG (DE) 2019-03-14 — — WO disclosed
EP-2850137-B1 MULTISTEP PROCESS FOR OBTAINING MODIFIED INORGANIC PARTICLES BOREALIS AGROLINZ MELAMINE (AT) 2017-07-05 — — EP disclosed
EP-2605853-B1 PROCESS FOR IMPROVING THE STORAGE STABILITY OF AQUEOUS COMPOSITE PARTICLE DISPERSIONS BASF SE (DE) 2017-04-19 — — EP disclosed
WO-2003096809-A1 ANTIMICROBIAL ACTIVE CARBON CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2003-11-27 — — WO disclosed
WO-2003068316-A1 COSMETIC FORMULATIONS THAT CONTAIN ANTIMICROBIAL POLYMERS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2003-08-21 — — WO disclosed
WO-2003068898-A1 WASHING AND CLEANING FORMULATIONS THAT CONTAIN ANTIMICROBIAL POLYMERS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2003-08-21 — — WO disclosed
WO-2003000760-A1 METHOD FOR PRODUCING AN AQUEOUS DISPERSION OF PARTICLES COMPOSED OF A POLYMER AND A FINE-PARTICLE INORGANIC SOLID BASF AKTIENGESELLSCHAFT (DE) 2003-01-03 — — WO disclosed
EP-1235869-A1 METHOD FOR PRODUCING AN AQUEOUS DISPERSION OF PARTICLES THAT ARE MADE UP OF POLYMERS AND INORGANIC SOLID MATTER WHICH CONSISTS OF FINE PARTICLES BASF AKTIENGESELLSCHAFT (DE) 2002-09-04 — — EP disclosed
WO-2001029106-A1 METHOD FOR PRODUCING AN AQUEOUS DISPERSION OF PARTICLES THAT ARE MADE UP OF POLYMERS AND INORGANIC SOLID MATTER WHICH CONSISTS OF FINE PARTICLES BASF AKTIENGESELLSCHAFT (DE) 2001-04-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200282075-A1 ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND ALB, ANXA6, CD63 PAOX 3169/4885EP300 3747/4885CYP2D6 3105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.